Themis Medicare Limited (THEMISMED.NS)
INR 123.32
(6.39%)
INR 123.32
(6.39%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 705.74 Million INR | 2.35% |
| 2022 | 689.52 Million INR | 13.39% |
| 2021 | 608.09 Million INR | 3.96% |
| 2020 | 584.94 Million INR | 7.12% |
| 2019 | 546.08 Million INR | 1.82% |
| 2018 | 536.34 Million INR | 8.19% |
| 2017 | 495.75 Million INR | -22.95% |
| 2016 | 643.39 Million INR | 10.04% |
| 2015 | 584.69 Million INR | -6.94% |
| 2014 | 628.3 Million INR | -5.14% |
| 2013 | 662.35 Million INR | 21.07% |
| 2012 | 547.06 Million INR | 14.68% |
| 2011 | 477.03 Million INR | 2.46% |
| 2010 | 465.59 Million INR | 9.3% |
| 2009 | 425.99 Million INR | -21.98% |
| 2008 | 546.02 Million INR | 23.79% |
| 2007 | 441.08 Million INR | 20.34% |
| 2006 | 366.52 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 645.53 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 705.74 Million INR | 2.35% |
| 2023 Q4 | 705.74 Million INR | 0.0% |
| 2023 Q2 | 596.36 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 545.41 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 689.52 Million INR | 13.39% |
| 2022 Q4 | 689.52 Million INR | 0.0% |
| 2021 Q4 | 608.09 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 580.04 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 608.09 Million INR | 3.96% |
| 2020 Q2 | 561.68 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 584.94 Million INR | 7.12% |
| 2020 Q4 | 584.94 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 514.66 Million INR | 0.0% |
| 2019 FY | 546.08 Million INR | 1.82% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 546.08 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q4 | 536.34 Million INR | 0.0% |
| 2018 FY | 536.34 Million INR | 8.19% |
| 2017 FY | 495.75 Million INR | -22.95% |
| 2017 Q4 | 495.75 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q2 | 450.87 Million INR | 0.0% |
| 2016 Q4 | 643.39 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 FY | 643.39 Million INR | 10.04% |
| 2016 Q2 | 589.95 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2015 FY | 584.69 Million INR | -6.94% |
| 2015 Q4 | 584.69 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 575.96 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2014 Q4 | 628.3 Million INR | 0.0% |
| 2014 FY | 628.3 Million INR | -5.14% |
| 2013 FY | 662.35 Million INR | 21.07% |
| 2012 Q4 | 547.06 Million INR | 0.0% |
| 2012 Q2 | 783.86 Million INR | 0.0% |
| 2012 FY | 547.06 Million INR | 14.68% |
| 2011 FY | 477.03 Million INR | 2.46% |
| 2010 FY | 465.59 Million INR | 9.3% |
| 2009 FY | 425.99 Million INR | -21.98% |
| 2008 FY | 546.02 Million INR | 23.79% |
| 2007 FY | 441.08 Million INR | 20.34% |
| 2006 FY | 366.52 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 95.706% |
| Hester Biosciences Limited | 755.81 Million INR | 6.624% |
| Aarti Drugs Limited | 4.85 Billion INR | 85.475% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 89.022% |
| Albert David Limited | 436.12 Million INR | -61.823% |
| Alembic Limited | 113.4 Million INR | -522.348% |
| Alkem Laboratories Limited | 26.61 Billion INR | 97.348% |
| Bafna Pharmaceuticals Limited | 296.41 Million INR | -138.09% |
| Bajaj HealthCare Limited | 1.44 Billion INR | 51.003% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -2667.945% |
| Brooks Laboratories Limited | 96.1 Million INR | -634.323% |
| Eris Lifesciences Limited | 1.89 Billion INR | 62.665% |
| FDC Limited | 3.88 Billion INR | 81.852% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 89.413% |
| Gufic Biosciences Limited | 2 Billion INR | 64.798% |
| Hikal Limited | 3.03 Billion INR | 76.763% |
| Ind-Swift Limited | 640.91 Million INR | -10.115% |
| Innova Captab Limited | 1.44 Billion INR | 50.996% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 83.388% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -370.589% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 94.527% |
| Lincoln Pharmaceuticals Limited | 771.68 Million INR | 8.545% |
| Lupin Limited | 49.53 Billion INR | 98.575% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | 42.919% |
| Medico Remedies Limited | 163.37 Million INR | -331.985% |
| Morepen Laboratories Limited | 2.48 Billion INR | 71.611% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 90.048% |
| Orchid Pharma Limited | 2.64 Billion INR | 73.29% |
| Procter & Gamble Health Limited | 1.09 Billion INR | 35.318% |
| RPG Life Sciences Limited | 1.01 Billion INR | 30.124% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -1669.666% |
| Sigachi Industries Limited | 707.2 Million INR | 0.207% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 80.38% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | 69.474% |
| Unichem Laboratories Limited | 7.04 Billion INR | 89.985% |
| Vaishali Pharma Limited | 3.79 Million INR | -18486.858% |
| Wanbury Limited | 360.23 Million INR | -95.913% |
| Windlas Biotech Limited | 621.89 Million INR | -13.484% |
| ZIM Laboratories Limited | 812.62 Million INR | 13.153% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -574.855% |
| Ipca Laboratories Limited | 24.71 Billion INR | 97.144% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.285% |
| Venus Remedies Limited | 1.21 Billion INR | 42.005% |
| Sakar Healthcare Limited | 277.32 Million INR | -154.484% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 99.28% |
| Divi's Laboratories Limited | 31.84 Billion INR | 97.783% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | 69.03% |
| Mankind Pharma Limited | 15.53 Billion INR | 95.457% |
| Sequent Scientific Limited | 3.46 Billion INR | 79.616% |
| Laurus Labs Limited | 18.45 Billion INR | 96.176% |
| Neuland Laboratories Limited | 3.5 Billion INR | 79.86% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 85.956% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 97.192% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 97.95% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -144.162% |
| Wockhardt Limited | 6.4 Billion INR | 88.973% |
| Bal Pharma Limited | 878.11 Million INR | 19.63% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 98.89% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | 40.417% |
| Par Drugs and Chemicals Limited | 41.77 Million INR | -1589.593% |
| Caplin Point Laboratories Limited | 3.63 Billion INR | 80.56% |
| Shilpa Medicare Limited | 3.44 Billion INR | 79.539% |
| Valiant Laboratories Limited | 100.15 Million INR | -604.658% |
| Ajanta Pharma Limited | 8.28 Billion INR | 91.48% |
| Aarey Drugs & Pharmaceuticals Limited | 346.75 Million INR | -103.526% |
| Granules India Limited | 13 Billion INR | 94.573% |
| Medicamen Biotech Limited | 593.75 Million INR | -18.862% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -234.769% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 96.903% |
| NATCO Pharma Limited | 7 Billion INR | 89.925% |
| Suven Life Sciences Limited | 7.08 Million INR | -9861.087% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -620.411% |
| Strides Pharma Science Limited | 11.26 Billion INR | 93.734% |
| Indoco Remedies Limited | 3.53 Billion INR | 80.011% |
| Alpa Laboratories Limited | 136.65 Million INR | -416.449% |
| Lasa Supergenerics Limited | 190.43 Million INR | -270.597% |
| Sun Pharma Advanced Research Company Limited | 14.79 Million INR | -4671.113% |